Dr. Dirk Jaeger is the managing director and the head of the Department of Medical Oncology at the National Center for Tumor Diseases of the University Clinic of Heidelberg, where he focuses on translating innovative immunotherapies into early clinical trials. Dr. Jaeger is a member of CRI’s Clinical Leadership Committee.
My close interactions with CRI and their international network of clinicians and research scientists has been—and will continue to be—crucial to the success of our own vaccine and immunotherapy programs.
¡Hagamos correr la voz sobre la inmunoterapia! Haga clic para compartir esta página con su comunidad.